🎧 #ChatsWithChaudhrey 𝐭𝐑𝐞 𝐏𝐨𝐝𝐜𝐚𝐬𝐭 🎧 S6E02 #ReflectionsandForecasts2526 E02 with Biosynth Philip Noone Jan 13th 2026

I was delighted to sit down with Philip Noone. CDir Executive Vice President Diagnostics at Biosynth as part of this years #ReflectionsandForecasts 2025/26 interview series, where I look back on the past year and look ahead to this.

I asked Philip.......

β—‰ 01:08 Who are Biosynth and what is your role?

2025 π‘πžπŸπ₯𝐞𝐜𝐭𝐒𝐨𝐧𝐬

β—‰ 02:12 What's been happening in Biosynth Diagnostics part of the business – what were the highlights for you?Β 

β—‰ 06:06 Are there are other materials you are looking to develop other #recombinant alternatives to?Β 

β—‰ 07:19 Tell more about some of the other developments at Biosynth in 2025?

β—‰ 09:21 What are the main challenges your customers have faced in 2025?

β—‰ 11:59 Are there major differences in the regulatory environments in the different geographic regions

β—‰ 11:59 What were the main challenges your customers faced in 2025?

β—‰ 14:39 How much of a impact has #Sustainability and #AI had in the #IVD and #Diagnostics sector?

β—‰ 19:09 Is there anything other new developments you saw in 2025 that you would like to highlight to viewers?

2026 π…π¨π«πžπœπšπ¬π­π¬

β—‰ 21:56 Looking forward toward 2026, what are you thoughts in terms of how the market will be?

β—‰ 24:28 What trends do you expect to see in 2026?

β—‰ 27:10 What else can we expect from Biosynth in 2026?

β—‰ 29:56 Finally what’s your New Year message to viewers?

What are your thoughts on what Philip has said. Agree? Disagree? Whatever your views we would love to hear from you.Β 

🎞 You can WATCH the podcast interview here https://lnkd.in/eTrnwawm πŸ’» You can learn more about Biosynth using the link below and get in touch with Philip directly via LinkedIn!

#RSKRF2526 #RSKBiosynth #diagnostics #biosynth #infectiousdiseases #Biotech #IVD #diagnosticreagentsΒ 


ΠžΡ‚Π·Ρ‹Π²Ρ‹


Podcastly – the best platform for podcasters and podcast lovers. More than 10 millions of audio content that available on Android/iOS/Web/Desktop and Telegram.